Phenylephrine Nasal |
4-Way Fast Acting; Afrin Children's Pump Mist; Ah-chew D; Little Colds; Little Noses Gentle Formula |
Clinical Trial: Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation
This study has been completed.
|
Purpose
The purpose of this study is to compare the efficacy on pupillary dilation between the single dose versus the three doses of 1% tropicamide with 10% phenylephrine for complete ocular examination.
| Condition | Intervention | Phase |
|---|---|---|
| Eye Diseases | Drug: 1% tropicamide and 10% phenylephrine | Phase III |
MedlinePlus related topics: Eye Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Primary Outcomes: horizontal pupil diameter
Secondary Outcomes: systolic blood pressure; diastolic blood pressure; heart rate; adverse drug reaction; time to pupil dilation greater than 6 mm
Expected Total Enrollment: 80
Secondary Outcomes: systolic blood pressure; diastolic blood pressure; heart rate; adverse drug reaction; time to pupil dilation greater than 6 mm
Expected Total Enrollment: 80
Study start: December 2004; Study completion: July 2005
Last follow-up: June 2005; Data entry closure: June 2005
To the best of the authors'''' knowledge, there have been no clinical trials using an appropriate regimen for pupillary dilation up until now. Therefore, the authors were interested to find out the most appropriate regimen for complete ocular examination, based on the finding that a pupil diameter of 6 mm or greater is adequate for indirect ophthalmoscopy. The authors hypothesize that a single dose of 1% tropicamide and 10% phenylephrine is adequate to complete the job and are conducting this prospective randomized clinical controlled trial to prove the hypothesis.
Eligibility
Ages Eligible for Study: 20 Years - 80 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- aged between 20 and 80 years old
- dark iris
- require binocular indirect ophthalmoscopy for complete ocular examination
- signed written consent forms
Exclusion Criteria:
- history of ocular trauma
- history of intraocular surgery
- history of laser treatment
- previous eye drop instillation that may affect pupillary dilation
- ocular diseases that may affect pupil size such as Horner’s syndrome, Adies’ pupil, glaucoma and uveitis
- history of diabetes mellitus, severe hypertension and cardiovascular diseases
Location Information
Thailand
Srinagarind Hospital, Khon Kaen, 40002, Thailand
Study chairs or principal investigators
Yosanan Yospaiboon, M.D., Principal Investigator, Faculty of Medicine, Khon Kaen University
More Information
Study ID Numbers: HE461104
Last Updated: July 18, 2005
Record first received: July 15, 2005
ClinicalTrials.gov Identifier: NCT00120432
Health Authority: Thailand: Khon Kaen University Ethics Committee for Human Research
ClinicalTrials.gov processed this record on 2005-08-02
Last Updated: July 18, 2005
Record first received: July 15, 2005
ClinicalTrials.gov Identifier: NCT00120432
Health Authority: Thailand: Khon Kaen University Ethics Committee for Human Research
ClinicalTrials.gov processed this record on 2005-08-02
Resources
- Afrin Childrens Pump Mist (Drug Digest)
- Ah-chew D (Drug Digest)

Not Signed In -

